Original language | English (US) |
---|---|
Pages (from-to) | 463-465 |
Number of pages | 3 |
Journal | Parkinsonism and Related Disorders |
Volume | 19 |
Issue number | 4 |
DOIs | |
State | Published - Apr 2013 |
All Science Journal Classification (ASJC) codes
- Neurology
- Geriatrics and Gerontology
- Clinical Neurology
Access to Document
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
The meaning of a "hippo" response on the Montreal Cognitive Assessment in Parkinson's disease. / Armstrong, Melissa J.; Duff-Canning, Sarah; Tang-Wai, David F.; Fox, Susan; Zadikoff, Cindy; Kennedy, Nancy; Gill, David; Eslinger, Paul J.; Mapstone, Mark; Chou, Kelvin L.; Persad, Carol; Litvan, Irene; Mast, Benjamin T.; Marras, Connie.
In: Parkinsonism and Related Disorders, Vol. 19, No. 4, 04.2013, p. 463-465.Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - The meaning of a "hippo" response on the Montreal Cognitive Assessment in Parkinson's disease
AU - Armstrong, Melissa J.
AU - Duff-Canning, Sarah
AU - Tang-Wai, David F.
AU - Fox, Susan
AU - Zadikoff, Cindy
AU - Kennedy, Nancy
AU - Gill, David
AU - Eslinger, Paul J.
AU - Mapstone, Mark
AU - Chou, Kelvin L.
AU - Persad, Carol
AU - Litvan, Irene
AU - Mast, Benjamin T.
AU - Marras, Connie
N1 - Funding Information: This study was supported by a grant from the Michael J. Fox Foundation . Melissa J. Armstrong: Support as an Edmond J. Safra fellow at Toronto Western Hospital while working on this project. Current research support from Abbott . Sarah Duff-Canning: Research support from Michael J Fox Foundation, National Parkinson Foundation , and Canadian Institutes of Health Research . Susan Fox: Research support from the Parkinson Society Canada, Michael J. Fox Foundation, and NIH. Consultancy from Teva, Novartis, Santhera, Merz, Merck Serono. Cindy Zadikoff: Research support from Parkinson Alliance . Consultancy and honoraria from Teva, GSK, Merz, Allergan, Ipsen, and Abbott. Paul J. Eslinger: Research support from National Institute of Health ( NS060722 , ES019672 , AG027771 ) and the Pennsylvania Department of Health . Mark Mapstone: Research support from the National Institute of Health, Michael J. Fox Foundation, Neurologix, Inc. , and Advanced Neuromodulation System, Inc . Honoraria from the Michael J. Fox Foundation. Kelvin L. Chou: Research support from the National Institute of Health ( NS44504-08 ) and participates as a site-PI in clinical trials sponsored by the HSG (PHAROS, 2CARE, and CREST-HD). Royalties from UpToDate. Speaking honoraria from Allergan. Consulting honoraria for Medtronic and Merz Pharmaceuticals. Carol Persad: Research support from National Institute of Health ( P01 NS015655-26A1 , MCASTL RFP2010-04 ). Irene Litvan: Research support from National Institute of Health ( R01 PAS-03-092 NIA), National Parkinson Foundation, Parkinson Support Center of Kentuckiana, CurePSP, Noscira, Allon Therapeutics, and Parkinson Study Group. Consultant for Teva, Novartis, Santhera, Merz, Merck Serono, and Bristol-Myers Squibb. Connie Marras: Research support from the Canadian Institutes of Health Research, Michael J. Fox Foundation, National Parkinson Foundation, Merck Serono and Allon Therapeutics. David F. Tang-Wai, Nancy Kennedy, David Gill, and Benjamin T. Mast report no disclosures. Funding Information: This study was supported by a grant from the Michael J. Fox Foundation. We would like to thank Fred Marshall, MD (Department of Neurology, University of Rochester), who also contributed to data collection and Brandon Rothberg, HBA (Toronto Western Hospital Movement Disorders Centre and the Edmond J. Safra Program in Parkinson's Disease) for assistance with the study database. Melissa J. Armstrong received support as an Edmond J. Safra fellow at Toronto Western Hospital while working on this project.
PY - 2013/4
Y1 - 2013/4
UR - http://www.scopus.com/inward/record.url?scp=84875248110&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84875248110&partnerID=8YFLogxK
U2 - 10.1016/j.parkreldis.2012.09.005
DO - 10.1016/j.parkreldis.2012.09.005
M3 - Letter
C2 - 23036511
AN - SCOPUS:84875248110
VL - 19
SP - 463
EP - 465
JO - Parkinsonism and Related Disorders
JF - Parkinsonism and Related Disorders
SN - 1353-8020
IS - 4
ER -